The United States will temporarily halt the use of the Johnson & Johnson COVID-19 vaccine, according to a report from the New York Post.
The decision to halt the use of the vaccine comes after six women — between the ages of 18 and 48 — developed blood clots.
Johnson & Johnson is the first single-dose vaccine on the market.
From the report:
One died and a second in Nebraska was hospitalized in critical condition. The feds hope the pause will serve as a strong signal to states to do the same.
There is no word on when the halt will be lifted, but the Centers for Disease Control and Prevention says 9 million more doses have been shipped to the country.
It is also important to put the number in context, and that blood clots from those receiving the shot are extremely rare.
For context, the CDC says roughly 900,000 Americans experience blood clots in a given year, out of 328 million people. This is 6 out of 6.8 million. https://t.co/eCw9QuwSmI
— Kathryn Watson (@kathrynw5) April 13, 2021
The coronavirus originated from animals and a majority of those who were infected early either worked at or frequently visited the Huanan seafood wholesale market in Wuhan, according to The Guardian. The virus is similar to Severe acute respiratory syndrome (Sars) and Middle Eastern respiratory syndrome (Mers).
The Wuhan coronavirus is transmitted from person to person through “droplet transmission.” That means an infected person can pass the virus by sneezing or coughing on another person as well as by direct contact.
While a majority of the cases have been detected in the United States and China — with more than 31.3 million confirmed cases and 562,000 deaths in the United States — it has now reached many countries around the world. It has also been confirmed in Italy, Australia, Canada, France, Germany, and many other eastern countries.